Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
EVE-112 Vaginal Ring
Product Overview
Alternative Name:
Etonogestrel (ENG) + ethinylestradiol (EE) vaginal ring; EVE112
Development Status:
Active Development
Target:
Female
Mode:
Hormonal
Delivery Type:
Vaginal Ring
Duration Type:
Short-acting
Description:
A vaginal ring expected to be a bioequivalent to NuvaRing. The new vaginal delivery system has not been disclosed and is being considered for a patent application.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
etonogestrel
,
ethinyl estradiol
Potential Multi-Purpose Technology (MPT):
No
Dose:
Etonogestrel: 5mg, ethinyl estradiol: 0.85mg
Partner:
Evestra, Inc.
,
Gedeon Richter Plc.
Status
Project Phase:
Late Development
Project Stage:
Phase II
Status Details:
Phase-II clinical trials are taking place in Germany and pre-clinical trials are underway in USA.
Programmatic Considerations
Additional Information
Additional Information:
Evestra, Inc. website
Phase II clinical trial
Download Product Report
